Milligram for milligram, methadone is substantially stronger than oxycodone. On a standard potency scale where oral morphine equals 1, oxycodone rates about 1.5 times stronger than morphine, while methadone rates 5 to 10 times stronger. That makes methadone roughly 3 to 7 times more potent than oxycodone by weight. But raw potency only tells part of the story, and it’s the other differences between these two drugs that make methadone far more dangerous to use without careful medical oversight.
How Potency Is Measured
Opioid strength is compared using something called morphine milligram equivalents, or MME. Morphine serves as the baseline (a potency of 1), and every other opioid is scored relative to it. Oxycodone lands at roughly 1.5, meaning 10 mg of oxycodone provides about the same pain relief as 15 mg of morphine. Methadone lands between 5 and 10 on that same scale, so a single 5 mg dose is equivalent to roughly 37.5 to 50 mg of morphine.
These numbers come from the World Health Organization’s opioid conversion tables and are used by clinicians worldwide when switching a patient from one opioid to another. But methadone has a caveat that no other common opioid shares: its relative potency isn’t fixed. It changes depending on the dose and how long someone has been taking it.
Why Methadone’s Strength Is Unpredictable
Most opioids behave in a fairly linear way. Double the dose, roughly double the effect. Methadone doesn’t follow this pattern. When taken as a single dose, a 5 mg tablet is equivalent to about 7.5 mg of morphine. But when taken regularly over days, methadone accumulates in the body and its effective potency climbs well beyond that initial ratio, sometimes exceeding the 5-to-10 range listed in conversion tables. The WHO specifically warns that methadone’s “variable long plasma half-life and broad-spectrum receptor affinity result in a much higher-than-expected relative potency when administered regularly” and recommends specialist guidance for any dose conversion involving the drug.
This accumulation happens because methadone leaves the body very slowly. It takes roughly five half-lives, about 5 days, for blood levels to stabilize after starting or changing a dose. During that window, each new dose adds to what’s still circulating from previous doses. A patient may feel fine on day one but experience dangerously high drug levels by day three or four without any change in their dosing. Oxycodone, by contrast, is largely cleared from the body within hours and reaches its peak effect much more predictably.
A Key Heart Risk Unique to Methadone
Methadone carries a cardiac risk that oxycodone does not. It can disrupt the electrical timing of the heart, prolonging what’s called the QT interval on an electrocardiogram. When this interval stretches too far (beyond 500 milliseconds), it increases the risk of a potentially fatal heart rhythm called torsades de pointes. The FDA issued a safety alert in 2006 specifically about fatalities and cardiac arrhythmias tied to methadone, and the drug’s labeling now includes a warning.
Because of this risk, expert panels recommend that patients with risk factors for heart rhythm problems get a baseline ECG before starting methadone and additional monitoring whenever doses exceed 120 mg per day. Patients who experience fainting spells, dizziness, palpitations, or seizures while on methadone need immediate cardiac evaluation. If the QT interval is found to be significantly prolonged, the typical response is to lower the dose, switch to a different medication, or stop methadone entirely. Oxycodone does not carry this same cardiac warning.
Different Drugs for Different Purposes
Despite being more potent, methadone is not simply a “stronger painkiller” prescribed when oxycodone isn’t enough. The two drugs occupy different roles in medicine. Oxycodone is widely prescribed for moderate to severe pain, available in both immediate-release and extended-release formulations, and is one of the most commonly used opioid painkillers in the United States. Methadone has a dual identity: it’s used for chronic pain, but it’s also one of the primary medications for treating opioid use disorder.
For addiction treatment, methadone works by activating the same brain receptors as other opioids but doing so more slowly and over a much longer period. This produces less euphoria while keeping withdrawal symptoms and cravings at bay. It has been used for this purpose for more than 50 years. In the U.S., methadone for addiction can only be dispensed through federally certified treatment programs, not through a standard pharmacy prescription. When used for pain, it can be prescribed more conventionally, but the slow accumulation and cardiac risks still demand closer monitoring than oxycodone typically requires.
Pain Relief: Stronger Doesn’t Mean Better
You might assume that a more potent opioid automatically provides superior pain control. The evidence doesn’t support that assumption, particularly for harder-to-treat pain types. A Cochrane review examining methadone for nerve pain found the evidence was very limited and very low quality. In one small study comparing methadone to morphine for neuropathic pain, morphine actually performed better. No study found that participants taking methadone achieved at least a 50% reduction in pain. The review concluded there is “insufficient evidence to support or reject the suggestion that methadone has any efficacy in any neuropathic pain condition.”
Methadone does have properties that are pharmacologically distinct from oxycodone. It interacts with serotonin pathways in a way that’s somewhat similar to tramadol, which was once thought to involve blocking a specific type of brain receptor (NMDA receptors). More recent analysis, however, has found that standard methadone doses used for pain are unlikely to have any meaningful interaction with NMDA receptors at all. This means some of the theoretical advantages attributed to methadone for complex pain may have been overstated.
Why the Potency Gap Matters for Safety
The practical takeaway is this: methadone is significantly more potent than oxycodone on a milligram-for-milligram basis, but that potency comes packaged with a set of risks that make it a fundamentally different drug to manage. Its slow buildup over days, its unpredictable dose-response relationship, and its ability to disrupt heart rhythm all mean that the margin for error is much narrower.
Someone who is used to taking oxycodone cannot simply switch to the “equivalent” dose of methadone calculated from a conversion chart. Those charts are starting points, not direct translations, and the nonlinear way methadone accumulates means the true effective dose may be far higher than what the math predicts. This is exactly why overdose deaths have occurred when patients or providers treated methadone like a straightforward oxycodone substitute. The drug’s potency is real, but so is its complexity.